Application of Two Neutral Mspl DNA Polymorphisms in the Analysis of Hereditary Protein C Deficiency

Summary

Screening of restriction erzyme digested DNA from normal and protein C deficient individuals with a variety of probes derived from the protein C locus has revealed the existence of two neutral MspI polymorphism. One polymorphism (MI), which is located ≈7 kb upstream of the protein C gene, has allelic frequencies of 69 and 31%, and was used to exclude extensive gene deletions as a likely cause of type I protein C deficiency in 50% of cases in a panel of 22 families. Furtherrnore, the same polymorphism has been used in 5 doubly affected individuals establishing compound heterozygosity in 3 of these.

The second, intragenic, polymorphism (MII) has allelic frequencies of 99 and 1% in the normal population. The frequency of the rare allele of this RFLP was with 7% much higher in a panel of 22 Dutch families with protein C deficiency. Interestingly, in all three probands that were heterozygous for MII the rare allele of MII coincided with a point mutation that leads to a stop codon in amino acid position 306 of the protein C coding sequence. This mutation may account for 14% of the protein C deficient individuals in The Netherlands.

• References

• 1 Fair DS, Marlar RA. Biosynthesis and secretion of factor VII, protein C, protein S and the protein C inhibitor from a human hepatoma cell line. Blood 1986; 67: 64-70
• 2 Sala N, Owen WG, Collen D. Functional level of protein C in human plasma. Blood 1984; 63: 671-675
• 3 Esmon CT. Protein C: biochemistry, physiology and clinical implications. Blood 1983; 62: 1155-1158
• 4 Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373
• 5 Broekmans AW, Veltkamp JJ, Bertina RM. Congenital protein C deficiency and venous thrombo-embolism. A study of three Dutch families. N Engl J Med 1983; 309: 340-344
• 6 Bertina RM. Prevelance of hereditary thrombophilia and the identification of genetic risk factors.. Fibrinolysis 1988; 2 (Suppl. 02) 7-13
• 7 Gladson CL, Scharrer I, Hack V, Beck KH, Griffin JH. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemostas 1988; 59: 18-22
• 8 Branson HE, Kaze J, Marble R, Griffin JH. Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulmi-nans in a newborn infant. Lancet 1983; ii: 1165-1168
• 9 Marlar RA, Montgomery RR, Broekmans AW. Diagnosis and treatment of homozygous protein C deficiency. J Pediat 1989; 114: 528-534
• 10 Bertina RM. Assays for protein C. In: Bertina RM. (ed) Protein C and Related Proteins Churchill Livingstone; Edinburgh: 1988: 130-150
• 11 Romeo G, Hassan HJ, Staempfli S, Roncuzzi L, Cianetti L, Leonardi A, Vicente V, Mannucci PM, Bertina RM, Peschle C, Cortese R. Hereditary thrombophilia: identification of nonsense and missense mutations in the protein C gene. Proc Natl Acad Sci USA 1987; 84: 2829-2832
• 12 Matsuda M, Sugo T, Sakata Y, Murayama H, Mimuro J, Tanabe S, Yoshitake S. A thrombotic state due to an abnormal protein C. N Engl J Med 1988; 319: 1265-1268
• 13 Francomano CA, Kazazian HH. DNA analysis in genetic disorders. Ann Rev Med 1986; 37: 377-395
• 14 Te Lintel HekkertW, Bertina RM, Reitsma PH. Two RFLP’s ≈ 7 kb 5’ of the protein C gene. Nucl Acids Res 1988; 16: 11849
• 15 Koenhen E, Bertina RM, Reitsma PH. MspI RFLP in intron 8 of the human protein C gene. Nucl Acids Res 1989; 17: 8401
• 16 Wehinger H, Geiger E, Freudenberg V, Schtirmann J, Alexandrakis EI, Witt I. Schwerer hereditarer Protein C-Mangel bei einem Neugeborenen mit Purpura fulminans – erfolgreiche Behandlung mit Phenprocoumon. Klin Padiat 1985; 197: 116-120
• 17 Pertrini P, Segnestam K, Ekelund H, Egber N. Homozygous protein C deficiency in two siblings. Pediatr Hematol Oncol 1990; 7: 151-168
• 18 Samama M, Horellou MH, Soria J, Conrad J, Nicolas G. Successful progressive anticoagulation in a severe protein C deficiency and previous skin necrosis at the initiation of oral anticoagulant treatment. Thromb Haemostas 1984; 51: 132-133
• 19 Bertina RM, Brockmans AW, Van der LindenI K, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemostas 1982; 48: 1-5
• 20 Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 8: 503-517
• 21 Rigby P WJ, Diekmann M, Rodes C, Berg P. Labelling deoxyribonucleic acid to high specific activity in-vitro by nicktranslation with DNA polymerase I. J Mol Biol 1977; 113: 237-254
• 22 Kogan SC, Doherty M, Gitschier J. An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. N Engl J Med 1987; 317: 985-990
• 23 Foster DC, Yoshitake S, Davie EW. The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 1985; 82: 4673-4677
• 24 Reitsma PH, Mandalaki F, Kasper CK, Bertina RM, Briet E. Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B ley den phenotype). Blood 1989; 73: 743-746
• 25 Green PM, Bentley DR, Mibashan RS, Nilsson IM, Gianelli F. Molecular pathology of haemophilia B. EMBO J 1989; 8: 1067-1072
• 26 Reitsma PH. Use of protein C DNA probes in the analysis of protein C-deficient families. In: Bertina RM. (ed) Protein C and Related Proteins. Churchill Livingstone; Edinburgh: 1988: 196-202